ANIK
Anika Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.44 / 10
Outperform
Sentiment is Outperform (6.44) and fund‑flow score 7.69 (good), with overall inflow ratio 0.46 but negative trends across all size segments. Analyst consensus is 100% Buy from one analyst, though his historical win rate is only 33.3%. Mixed optimism.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionBarrington Research
Times predicted6
Historical Win Rate33.3%
What is the market sentiment for ANIK?
- ANIK holds a Bullish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.44/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
